Keyphrases
Acute Allograft Rejection
100%
Transplantation
100%
Chronic Allograft Dysfunction
100%
Novel Therapies
100%
Multi-organ
66%
Organ Dysfunction
66%
Costimulation Blockade
66%
B-cell Depletion
66%
Organ-specific
66%
Anti-HLA Alloantibodies
66%
Alloimmune Response
66%
Molecular Assay
33%
B Cells
33%
University of California
33%
T Cell Activation
33%
Harvard
33%
Effector Function
33%
Renal Transplant
33%
Transplant Center
33%
Long-term Survival
33%
Pathological Changes
33%
Mechanism of Action
33%
Anti-CD20
33%
Attenuation
33%
Prevention of Progression
33%
T Cell Recognition
33%
Transplant Activity
33%
Humoral Rejection
33%
Allograft Survival
33%
End-stage Organ Failure
33%
Transplant Program
33%
Mechanistic Studies
33%
Costimulation
33%
Surrogate Marker
33%
Graft Dysfunction
33%
LEA29Y
33%
San Francisco
33%
Humoral Immune Response
33%
Expression Pattern
33%
Alloimmune
33%
Alloantigen
33%
Alloantibody
33%
Renal Function Improvement
33%
Cardiac Transplant Recipients
33%
T Cells
33%
Renal Allograft Recipient
33%
Acute Rejection
33%
Activation Function
33%
Functional Markers
33%
Organ Transplant Recipients
33%
Chronic Allograft Nephropathy
33%
Treatment Choice
33%
Function Change
33%
Transplant Recipients
33%
Antibody Production
33%
Renal Transplant Recipients
33%
Rituximab
33%
Calcineurin Inhibitors
33%
Medicine and Dentistry
Allograft
100%
Graft Rejection
100%
B Cell
100%
Alloantibody
100%
Kidney Graft
66%
T Cell
66%
Chronic Allograft Nephropathy
33%
Rituximab
33%
Heart Graft
33%
Disease Marker
33%
CD20
33%
Calcineurin Inhibitor
33%
Kidney Function
33%
Long Term Survival
33%
Chronic Graft Rejection
33%
Graft Survival
33%
Humoral Rejection
33%
Graft Dysfunction
33%
Kidney Allograft
33%
Alloantigen
33%
T Cell Activation
33%
Humoral Immunity
33%
Antibody Generation
33%
Immunology and Microbiology
Allograft
100%
Transplant Rejection
60%
B Cell
60%
Alloantibody
60%
T Cell
40%
CD20
20%
Kidney Function
20%
Rituximab
20%
Alloantigen
20%
Long Term Survival
20%
Humoral Immunity
20%
T Cell Activation
20%
Chronic Graft Rejection
20%
Chronic Allograft Nephropathy
20%
Antibody Generation
20%